Brief: Matas Q3 EBITDA Ex. Items Up At DKK 292.8 Mln

Matas A/S

25/02/2021 07:15

Feb 25 (Reuters) - Matas A/S  MATAS.CO :
    * SALES GROWTH DRIVEN BY INCREASING DEMAND FOR HEALTHCARE AND HEALTH PRODUCTS
    * GENERATED REVENUE OF DKK 1,313.0 MILLION IN Q3 2020/21, A YEAR-ON-YEAR INCREASE OF DKK
139.6
MILLION, OR 11.9%
    * EBITDA BEFORE SPECIAL ITEMS CAME TO DKK 292.8 MILLION IN Q3, A YEAR-ON-YEAR INCREASE OF
DKK 28.9
MILLION
    * Q3 SALES WERE BOOSTED BY PAY-OUT OF FROZEN HOLIDAY PAY, WHILE PHYSICAL STORE SALES WERE
ADVERSELY AFFECTED BY NEW RESTRICTIONS
    * FULL-YEAR GUIDANCE FURTHER UPGRADED
    * MATAS NOW FORECASTS GROWTH OF MORE THAN 12% IN BOTH OVERALL REVENUE AND UNDERLYING
REVENUE,
COMPARED WITH PREVIOUS ESTIMATE OF 10%
EBITDA MARGIN IS NOW EXPECTED TO EXCEED 18.5%, COMPARED WITH PREVIOUS ESTIMATE OF MORE THAN 18%
    * CAPEX ESTIMATE IS MAINTAINED AT DKK 120 - 140 MILLION.
    * AMBITION FOR FINANCIAL YEAR 2022/23, AS SET OUT IN 'RENEWING MATAS' STRATEGY, IS TO GROW
REVENUE
TO ABOUT DKK 4 BILLION
    * MATAS' AMBITION FOR FINANCIAL YEAR 2022/23, AS SET OUT IN 'RENEWING MATAS' STRATEGY, IS TO
GROW
REVENUE TO ABOUT DKK 4 BILLION AND KEEP ITS EARNINGS CAPACITY, IN TERMS OF EBITDA MARGIN BEFORE
SPECIAL ITEMS, ABOVE 18%.


Source text for Eikon:  ID:nGNE6WNgc3 
Further company coverage:  MATAS.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))